Trial Profile
Strategic Use of New Generation Antidepressants for Depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary) ; Sertraline (Primary)
- Indications Depression; Depressive disorders
- Focus Therapeutic Use
- Acronyms SUN-D
- 20 May 2013 Planned end date changed from 1 Mar 2013 to 1 Oct 2015 as reported by ClinicalTrials.gov.
- 28 Feb 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 26 Apr 2010 New trial record